Peter M Ferguson

16PUBLICATIONS
112CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyMedical biotechnology diagnostics (incl. biosensors)Tumour immunologyImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Oct 21, 2025
Clinical Letter: Rapidly Progressive TEN Secondary to Nivolumab and Relatlimab in a Patient With Metastatic Gastric Mucosal Melanoma.

Serene Chan, Peter Ferguson, Linda Chan

|Aug 12, 2025
A Clinical Perspective on Melanoma Overdiagnosis.

Jennifer Sheerin, Helena Collgros, Alex Chamberlain

|Jan 14, 2025
Impact of alternative diagnostic labels for melanoma in situ on management choices and psychological outcomes: protocol for an online randomised study.

Zhuohan Wu, Brooke Nickel, Farzaneh Boroumand

|Oct 02, 2024
The Prognostic Significance of Tumoral Melanosis.

Alison J Potter, Peter M Ferguson, Serigne N Lo

|Apr 08, 2024
Stroma-infiltrating T cell spatiotypes define immunotherapy outcomes in adolescent and young adult patients with melanoma.

Xinyu Bai, Grace H Attrill, Tuba N Gide

|Jan 19, 2024
CD4<sup>+</sup> T cell immunity against cutaneous melanoma encompasses multifaceted MHC II-dependent responses.

Emma G Bawden, Teagan Wagner, Jan Schröder

Pageof 3

Frequent Collaborators

13 joint publications

Richard A Scolyer

5 joint publications

James S Wilmott

4 joint publications

John F Thompson

4 joint publications

Georgina V Long